Molecular Imaging and Biology

, Volume 16, Issue 2, pp 167–172 | Cite as

Quantitative Liver Lesion Volume Determination by Nanoparticle-Based SPECT

  • Dániel S. Veres
  • Domokos Máthé
  • Ildikó Futó
  • Ildikó Horváth
  • Ákos Balázs
  • Kinga Karlinger
  • Krisztián Szigeti
Brief Article



The aim of this paper is to present a simple and quantitative data analysis method with a new potential in the application of liver single-photon emission computed tomography (SPECT) imaging. We have established quantitative SPECT/computed tomography (CT) in vivo imaging protocols for determination of liver tumor burden based on the known role of Kupffer cells in cancer of the liver.


As it is also known that functional Kupffer cells accumulate particulate material contained in the arterial blood of liver supply, we used radiolabeled macro-aggregated albumin particles ([99mTc]-MAA) injected intravenously to image liver disease. Quantification of cold spot liver lesion imaging was also a general objective.


We examined a healthy control group (BALB/C mice, n = 6) and group of induced hepatocellular carcinoma (HCC, matrilin-2 transgenic KO mice, n = 9), where hepatocellular carcinoma was induced by diethylnitrosamine. We used [99mTc]-MAA as radiopharmaceutical for liver SPECT imaging in a small animal SPECT/CT system. A liver radioactivity overview map was generated. Segmentation of the liver was calculated by Otsu thresholding method. Based on the segmentation the radioactivity volume and the summarized liver activity were determined.


Tumor burden of the livers was quantitatively determined by creating parametric data from the resulting volumetric maps. Ex vivo liver mass data were applied for the validation of in vivo measurements. An uptake with cold spots as tumors was observed in all diseased animals in SPECT/CT scans. Isotope-labeled particle uptake (standardized uptake concentration) of control (median 0.33) and HCC (median 0.18) groups was significantly different (p = 0.0015, Mann Whitney U test).


A new potential application of [99mTc]-MAA was developed and presents a simple and very effective means to quantitatively characterize liver cold spot lesions resulting from Kupffer cell dysfunctions as a consequence of tumor burden.

Key words

Hepatocellular carcinoma (HCC) SPECT/CT Quantification Particle Macro-aggregated albumin Kupffer cell 



The authors thank Dr. László Puskás and Ibolya Kiss for the animal models and Dr. Miklós Kellermayer for his support. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. HEALTH-F2-2011-278850 (INMiND), from the grant of the Hungarian Government's National Research and Development Office (NKTH-“AVINOMID”). This research was conducted in the framework of a Master Research Agreement of Semmelweis University and Mediso, Ltd., and a Research Agreement of Basic Medical Sciences Centre, Semmelweis University, and CROmed, Ltd.

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

11307_2013_679_MOESM1_ESM.docx (785 kb)
ESM 1 (DOCX 785 kb)


  1. 1.
    Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485–1491PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Oliva MR, Saini S (2004) Liver cancer imaging: role of CT, MRI, US and PET. Canc Imaging 4(Spec No A):S42–S46CrossRefGoogle Scholar
  3. 3.
    Qayyum A (2009) Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics 29:1797–1810PubMedCrossRefGoogle Scholar
  4. 4.
    Sica GT, Ji H, Ros PR (2000) CT and MR imaging of hepatic metastases. Am J Roentgenol 174:691–698CrossRefGoogle Scholar
  5. 5.
    Hammerstingl R, Huppertz A, Breuer J et al (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467PubMedCrossRefGoogle Scholar
  6. 6.
    Histed SN, Lindenberg ML, Mena E et al (2012) Review of functional/anatomical imaging in oncology. Nucl Med Comm 33:349–361CrossRefGoogle Scholar
  7. 7.
    Delbeke D, Pinson CW (2003) 11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med 44(2):222–223PubMedGoogle Scholar
  8. 8.
    Yamamoto Y, Nishiyama Y, Kameyama R et al (2008) Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. J Nucl Med 49:1245–1248PubMedCrossRefGoogle Scholar
  9. 9.
    Wudel LJ Jr, Delbeke D, Morris D et al (2003) The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg 69:117–124, Discussion pp. 124-126PubMedGoogle Scholar
  10. 10.
    Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945PubMedCrossRefGoogle Scholar
  11. 11.
    Hustinx R, Paulus P, Jacquet N et al (1998) Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Ann Oncol 9:397–401PubMedCrossRefGoogle Scholar
  12. 12.
    Bieze M, Bennink RJ, El-Massoudi Y et al (2013) The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy. Nucl Med Comm 34:146–154CrossRefGoogle Scholar
  13. 13.
    Ziessman HA, Wahl RL, Juni JE et al (1985) The utility of SPECT for 99mTc-MAA hepatic arterial perfusion scintigraphy. Am J Roentgen 145:747–751CrossRefGoogle Scholar
  14. 14.
    Satoh K, Yamamoto Y, Nishiyama Y et al (2003) 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med 17(1):61–67PubMedCrossRefGoogle Scholar
  15. 15.
    Saini S, Stark DD, Hahn PF et al (1987) Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiol 162:217–222Google Scholar
  16. 16.
    Liu K, He X, Lei XZ et al (2003) Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J Gastroenterol 9:1946–1949PubMedGoogle Scholar
  17. 17.
    George EA, Hendershott LR, Klos DJ, Donati RM (1980) Mechanism of hepatic extraction of gelatinized 99m technetium sulfur colloid. Eur J Nucl Med 5:241–245PubMedCrossRefGoogle Scholar
  18. 18.
    Tanimoto A, Kuribayashi S (2006) Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 58:200–216PubMedCrossRefGoogle Scholar
  19. 19.
    Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cyber 9:62–66CrossRefGoogle Scholar
  20. 20.
    Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32:623–648, discussion 49-50PubMedGoogle Scholar
  21. 21.
    Woodard HQ, Bigler RE, Freed B (1975) Letter: expression of tissue isotope distribution. J Nucl Med 16:958–959PubMedGoogle Scholar
  22. 22.
    Finucane CM, Murray I, Sosabowski JK et al (2011) Quantitative accuracy of low-count SPECT imaging in phantom and in vivo mouse studies. Int J Mol Imag 2011:197381Google Scholar
  23. 23.
    Goldfarb S, Pugh TD, Koen H, He YZ (1983) Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy. Environ Health Perspect 50:149–161PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Gordon S (1995) The macrophage. Bioessays 17:977–986PubMedCrossRefGoogle Scholar
  25. 25.
    Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Review Immunol 17:593–623CrossRefGoogle Scholar

Copyright information

© World Molecular Imaging Society 2013

Authors and Affiliations

  • Dániel S. Veres
    • 1
  • Domokos Máthé
    • 2
  • Ildikó Futó
    • 1
  • Ildikó Horváth
    • 1
  • Ákos Balázs
    • 3
  • Kinga Karlinger
    • 4
  • Krisztián Szigeti
    • 1
  1. 1.Department of Biophysics and Radiation BiologySemmelweis UniversityBudapestHungary
  2. 2.CROmed Translational Research CentersBudapestHungary
  3. 3.1st Department of SurgerySemmelweis UniversityBudapestHungary
  4. 4.Department of Radiology and OncotherapySemmelweis UniversityBudapestHungary

Personalised recommendations